Vivos Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of VVOS for the last quarter is 3.25 M USD, and it's 1.61% lower compared to the previous quarter. The net income of Q4 23 is -4.26 M USD.